Michal Marciniec
Overview
Explore the profile of Michal Marciniec including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Popek-Marciniec S, Zmorzynski S, Koczkodaj D, Marciniec M, Wasik-Szczepanek E, Karczmarczyk A, et al.
Acta Haematol
. 2023 Apr;
146(4):277-286.
PMID: 37015191
Introduction: Both microenvironmental signals from surrounding cells and changes in the genome of leukemic cells play essential role in the development of chronic lymphocytic leukemia. Nurse-like cells (NLCs) are one...
2.
Sapko K, Jamroz-Wisniewska A, Wozniak A, Marciniec M, Kulczynski M, Janczarek M, et al.
Ann Agric Environ Med
. 2022 Mar;
29(1):157-161.
PMID: 35352921
Introduction: Susac syndrome (SuS) is a disease manifested as the clinical triad of encephalopathy, branch retinal artery occlusion, and loss of sensory neural hearing. Case Report: The case is presented...
3.
Marciniec M, Szczepanska-Szerej A, Papuc E, Rejdak K
Int J Neurosci
. 2020 Dec;
132(10):1026-1030.
PMID: 33295845
Aims: Cervical pain is one of the most common non-motor symptoms of cervical dystonia (CD) and affects from 54.6% to 88.9% of patients. To date, minority of studies investigated the...
4.
Sapko K, Jamroz-Wisniewska A, Marciniec M, Kulczynski M, Szczepanska-Szerej A, Rejdak K
Neurol Neurochir Pol
. 2020 Oct;
55(1):117.
PMID: 33026645
No abstract available.
5.
Marciniec M, Szczepanska-Szerej A, Rejdak K
Neurol Res
. 2020 Jul;
42(11):987-991.
PMID: 32693754
Objectives: Botulinum toxin (BoNT) is an effective first-line treatment for cervical dystonia (CD). Despite generally good therapeutic efficacy, approximately 20-40% of CD patients do not achieve acceptable relief of the...
6.
Sapko K, Jamroz-Wisniewska A, Marciniec M, Kulczynski M, Szczepanska-Szerej A, Rejdak K
Neurol Neurochir Pol
. 2020 May;
54(3):252-258.
PMID: 32462652
Introduction: Multiple Sclerosis (MS) is a chronic, demyelinating disease of the central nervous system which affects mostly young people. Because it leads to disability and cognitive impairment, it is crucial...
7.
Marciniec M, Sapko K, Kulczynski M, Popek-Marciniec S, Szczepanska-Szerej A, Rejdak K
Clin Neurol Neurosurg
. 2019 Oct;
187:105561.
PMID: 31634685
Cervical artery dissection (CAD) is a leading cause of ischaemic stroke (IS) in young and middle-aged adults. Despite well characterized clinical presentation, the diagnosis of CAD can be quite challenging...
8.
Marciniec M, Szczepanska-Szerej A, Kulczynski M, Sapko K, Popek-Marciniec S, Rejdak K
Rev Neurosci
. 2019 Mar;
30(7):771-779.
PMID: 30917105
Pain is the most common and disabling non-motor symptom in cervical dystonia (CD). Up to 88.9% of patients report pain at some point in the course of the disease. It...